Long COVID-19 Syndrome and Sudden Cardiac Death: The Phantom Menace

Curr Med Chem. 2024;31(1):2-6. doi: 10.2174/0929867330666230515145041.

Authors

Michael Spartalis¹, David Zweiker², Eleftherios Spartalis³, Dimitrios C Iliopoulos³, Gerasimos Siasos¹

Affiliations

¹ 3rd Department of Cardiology, Sotiria Thoracic Diseases General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
² Department of Cardiology, Medical University of Graz, Graz, Austria.
³ Laboratory of Experimental Surgery and Surgical Research 'N.S. Christeas', National and Kapodistrian University of Athens, Medical School, Athens, Greece.

PMID: 37190817
DOI: 10.2174/0929867330666230515145041

No abstract available

Keywords: Long COVID-19; arrhythmia; myocardial injury; myocarditis; sudden cardiac death; ventricular.

MeSH terms

Anti-Arrhythmia Agents / therapeutic use
COVID-19*
Death, Sudden, Cardiac / etiology
Humans
Post-Acute COVID-19 Syndrome*

Substances

Anti-Arrhythmia Agents